|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 10/05/21 Rite Aid Corp. 10-Q 8/28/21 97:13M Toppan Merrill Bridge/FA |
Document/Exhibit Description Pages Size
1: 10-Q Quarterly Report HTML 1.70M
2: EX-4.12 Instrument Defining the Rights of Security Holders HTML 36K
3: EX-4.13 Instrument Defining the Rights of Security Holders HTML 36K
4: EX-22 Published Report re: Matters Submitted to a Vote HTML 40K
of Security Holders
5: EX-31.1 Certification -- §302 - SOA'02 HTML 29K
6: EX-31.2 Certification -- §302 - SOA'02 HTML 30K
7: EX-32 Certification -- §906 - SOA'02 HTML 28K
14: R1 Document and Entity Information HTML 77K
15: R2 Condensed Consolidated Balance Sheets HTML 132K
16: R3 Condensed Consolidated Balance Sheets HTML 35K
(Parenthetical)
17: R4 Condensed Consolidated Statements of Operations HTML 109K
18: R5 Condensed Consolidated Statements of Comprehensive HTML 52K
Income (Loss)
19: R6 Condensed Consolidated Statements of Comprehensive HTML 28K
Income (Loss) (Parenthetical)
20: R7 Condensed Consolidated Statements of Stockholders' HTML 112K
Equity
21: R8 Condensed Consolidated Statements of Stockholders' HTML 28K
Equity (Parenthetical)
22: R9 Condensed Consolidated Statements of Cash Flows HTML 136K
23: R10 Basis of Presentation and Significant Accounting HTML 71K
Policies
24: R11 Acquisition HTML 90K
25: R12 Restructuring HTML 156K
26: R13 Asset Sale to WBA HTML 74K
27: R14 Income (Loss) Per Share HTML 82K
28: R15 Facility Exit and Impairment Charges HTML 139K
29: R16 Fair Value Measurements HTML 30K
30: R17 Income Taxes HTML 32K
31: R18 Medicare Part D HTML 32K
32: R19 Manufacturer Rebates Receivables HTML 27K
33: R20 Goodwill and Other Intangible Assets HTML 118K
34: R21 Indebtedness and Credit Agreements HTML 85K
35: R22 Leases HTML 158K
36: R23 Stock Options and Stock Awards HTML 60K
37: R24 Retirement Plans HTML 61K
38: R25 Segment Reporting HTML 202K
39: R26 Commitments, Contingencies and Guarantees HTML 44K
40: R27 Supplementary Cash Flow Data HTML 43K
41: R28 Basis of Presentation and Significant Accounting HTML 76K
Policies (Policies)
42: R29 Basis of Presentation and Significant Accounting HTML 61K
Policies (Tables)
43: R30 Acquisition (Tables) HTML 97K
44: R31 Restructuring (Tables) HTML 155K
45: R32 Asset Sale to WBA (Tables) HTML 72K
46: R33 Income (Loss) Per Share (Tables) HTML 80K
47: R34 Facility Exit and Impairment Charges (Tables) HTML 135K
48: R35 Goodwill and Other Intangible Assets (Tables) HTML 208K
49: R36 Indebtedness and Credit Agreements (Tables) HTML 65K
50: R37 Leases (Tables) HTML 190K
51: R38 Stock Options and Stock Awards (Tables) HTML 59K
52: R39 Retirement Plans (Tables) HTML 57K
53: R40 Segment Reporting (Tables) HTML 201K
54: R41 Supplementary Cash Flow Data (Tables) HTML 42K
55: R42 Basis of Presentation and Significant Accounting HTML 66K
Policies (Details)
56: R43 Acquisition (Details) HTML 33K
57: R44 Acquisition - Purchase price allocation (Details) HTML 78K
58: R45 Acquisition - Intangible assets acquired (Details) HTML 35K
59: R46 Acquisition - Acquisition costs (Details) HTML 33K
60: R47 Acquisition - Proforma information (Details) HTML 54K
61: R48 Restructuring (Details) HTML 97K
62: R49 Asset Sale to WBA (Details) HTML 60K
63: R50 Asset Sale to WBA - Operating results of HTML 54K
discontinued operations (Details)
64: R51 Income (Loss) Per Share (Details) HTML 54K
65: R52 Facility Exit and Impairment Charges (Details) HTML 53K
66: R53 Facility Exit and Impairment Charges - Fair value HTML 49K
(Details)
67: R54 Facility Exit and Impairment Charges - Closed HTML 53K
Store Liability rollforward (Details)
68: R55 Fair Value Measurements (Details) HTML 35K
69: R56 Income Taxes (Details) HTML 38K
70: R57 Medicare Part D (Details) HTML 49K
71: R58 Manufacturer Rebates Receivables (Details) HTML 26K
72: R59 Goodwill and Other Intangibles - Goodwill HTML 35K
(Details)
73: R60 Goodwill and Other Intangible Assets - Intangibles HTML 73K
(Details)
74: R61 Goodwill and Other Intangible Assets - Unfavorable HTML 41K
lease intangibles and amortization expense
(Details)
75: R62 Indebtedness and Credit Agreements - Indebtedness HTML 92K
and lease financing obligations (Details)
76: R63 Indebtedness and Credit Agreement - Credit HTML 118K
Facility (Details)
77: R64 Indebtedness and Credit Agreement - Transactions HTML 93K
and Maturity (Details)
78: R65 Leases (Details) HTML 59K
79: R66 Leases - Supplemental cash flow information HTML 38K
related to leases (Details)
80: R67 Leases - Supplemental B/S Information (Details) HTML 59K
81: R68 Leases - Maturity of lease liabilities under HTML 86K
finance and operating leases (Details)
82: R69 Leases - Sale/Leaseback (Details) HTML 35K
83: R70 Stock Options and Stock Awards (Details) HTML 30K
84: R71 Stock Options and Stock Awards - Options (Details) HTML 35K
85: R72 Stock Options and Stock Awards- Restricted Stock, HTML 55K
etc. (Details)
86: R73 Retirement Plans - Net periodic cost (Details) HTML 42K
87: R74 Retirement Plans - Benefit obligation and funded HTML 39K
status (Details)
88: R75 Retirement Plans - Assumptions and assets HTML 28K
(Details)
89: R76 Segment Reporting - Balance Sheet information HTML 52K
(Details)
90: R77 Segment Reporting - Revenues (Details) HTML 59K
91: R78 Segment Reporting - Adjusted EBITDA (Details) HTML 72K
92: R79 Commitments, Contingencies and Guarantees HTML 63K
(Details)
93: R80 Supplementary Cash Flow Data (Details) HTML 44K
95: XML IDEA XML File -- Filing Summary XML 175K
13: XML XBRL Instance -- rad-20210828x10q_htm XML 3.73M
94: EXCEL IDEA Workbook of Financial Reports XLSX 123K
9: EX-101.CAL XBRL Calculations -- rad-20210828_cal XML 285K
10: EX-101.DEF XBRL Definitions -- rad-20210828_def XML 793K
11: EX-101.LAB XBRL Labels -- rad-20210828_lab XML 1.57M
12: EX-101.PRE XBRL Presentations -- rad-20210828_pre XML 1.20M
8: EX-101.SCH XBRL Schema -- rad-20210828 XSD 211K
96: JSON XBRL Instance as JSON Data -- MetaLinks 466± 686K
97: ZIP XBRL Zipped Folder -- 0001558370-21-012998-xbrl Zip 347K
Exhibit 4.13
SUPPLEMENTAL INDENTURE
SUPPLEMENTAL INDENTURE (this “Supplemental Indenture”) dated as of August 27, 2021, among The Bartell Drug Company, a Washington corporation (the “New Subsidiary Guarantor”), a subsidiary of Rite Aid Corporation (or its successor), a Delaware corporation (the “Company”), the Company on behalf of itself and the Subsidiary Guarantors (the “Existing Subsidiary Guarantors”) under the indenture referred to below, and The Bank of New York Mellon Trust Company, N.A., a banking association organized under the laws of the United States of America, as trustee (in such capacity, “Trustee”) and as notes collateral agent (in such capacity, “Notes Collateral Agent”) under the indenture referred to below.
W I T N E S S E T H :
WHEREAS the Company and the Existing Subsidiary Guarantors have heretofore executed and delivered to the Trustee an Indenture (the “Indenture”) dated as of July 27, 2020, providing for the issuance of an unlimited aggregate principal amount of 8.000% Senior Secured Notes due 2026 (the “Securities”);
WHEREAS Section 4.09 of the Indenture provides that under certain circumstances the Company is required to cause the New Subsidiary Guarantor to execute and deliver to the Trustee a supplemental indenture pursuant to which the New Subsidiary Guarantor shall unconditionally guarantee all the Company’s obligations under the Securities pursuant to a Subsidiary Guarantee on the terms and conditions set forth herein; and
WHEREAS pursuant to Section 9.01 of the Indenture, the Trustee, the Company and the Existing Subsidiary Guarantors are authorized to execute and deliver this Supplemental Indenture;
NOW THEREFORE, in consideration of the foregoing and for other good and valuable consideration, the receipt of which is hereby acknowledged, the New Subsidiary Guarantor, the Company, the Existing Subsidiary Guarantors and the Trustee mutually covenant and agree for the equal and ratable benefit of the Holders of the Securities as follows:
| 1. | Agreement to Guarantee. The New Subsidiary Guarantor hereby agrees, jointly and severally, on a senior secured basis, with all other Subsidiary Guarantors, to unconditionally guarantee the Company’s obligations under the Securities and the Indenture on the terms and subject to the conditions set forth in Article X of the Indenture and to be bound by all other applicable provisions of the Indenture. |
| 2. | Ratification of Indenture; Supplemental Indentures Part of Indenture. Except as expressly amended hereby, the Indenture is in all respects ratified and confirmed and all the terms, conditions and provisions thereof shall remain in full force and effect. This Supplemental Indenture shall form a part of the Indenture for all purposes, and every holder of Securities heretofore or hereafter authenticated and delivered shall be bound hereby. |
| 3. | Governing Law. THIS SUPPLEMENTAL INDENTURE SHALL BE GOVERNED BY, AND CONSTRUED IN ACCORDANCE WITH, THE LAWS OF THE STATE OF NEW YORK BUT WITHOUT REFERENCE TO APPLICABLE PRINCIPLES OF CONFLICTS OF LAW. |
| 4. | Trustee Makes No Representation. The Trustee makes no representation as to the validity or sufficiency of this Supplemental Indenture and shall not be responsible for the recitals contained herein, all which recitals are made solely by the other parties hereto. |
| 5. | Counterparts. The parties may sign any number of copies of this Supplemental Indenture. Each signed copy shall be an original, but all of them together represent the same agreement. |
| 6. | Effect of Headings. The Section headings herein are for convenience only and shall not effect the construction thereof. |
[Remainder of Page Intentionally Left Blank]
2
IN WITNESS WHEREOF, the parties hereto have caused this Supplemental Indenture to be duly executed as of the date first above written.
THE BARTELL DRUG COMPANY
By: /s/ Ron Chima
Name:Ron Chima
Title:Vice President
RITE AID CORPORATION, on behalf of itself and the existing subsidiary guarantors
By: /s/
Matthew Schroeder
Name:Matthew Schroeder
Title:Chief Financial Officer
THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A., as trustee
By: /s/ Lawrence M. Kusch
Name:Lawrence M. Kusch
Title:Vice President
THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A., as notes collateral agent,
By: /s/ Lawrence M. Kusch
Name:Lawrence
M. Kusch
Title:Vice President
[Signature Page to Supplemental Indenture for the 2025 Notes]
| This ‘10-Q’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| Filed on: | 10/5/21 | |||
| For Period end: | 8/28/21 | |||
| 8/27/21 | ||||
| 7/27/20 | 8-K | |||
| List all Filings | ||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 10/18/23 Rite Aid Corp. 10-Q 9/02/23 88:12M Toppan Merrill Bridge/FA 7/11/23 Rite Aid Corp. 10-Q 6/03/23 79:9.5M Toppan Merrill Bridge/FA 5/01/23 Rite Aid Corp. 10-K 3/04/23 131:22M Toppan Merrill Bridge/FA 1/04/23 Rite Aid Corp. 10-Q 11/26/22 92:13M Toppan Merrill Bridge/FA 10/05/22 Rite Aid Corp. 10-Q 8/27/22 89:12M Toppan Merrill Bridge/FA 7/06/22 Rite Aid Corp. 10-Q 5/28/22 88:10M Toppan Merrill Bridge/FA 4/25/22 Rite Aid Corp. 10-K 2/26/22 131:21M Toppan Merrill Bridge/FA 1/05/22 Rite Aid Corp. 10-Q 11/27/21 95:13M Toppan Merrill Bridge/FA 10/21/21 Rite Aid Corp. S-3ASR 10/21/21 6:1.9M Toppan Merrill/FA |